Skip to content
Transpact Enterprises logo

Transpact Enterprises

542765 BSE
Price unavailable

Transpact Enterprises (TRANSPACT) share price was ₹96.00 at the 28 Oct 2026 close; market capitalisation ₹3.68 Cr; sector Healthcare. The share price fell 57.2% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue was ₹0.09 Cr, against ₹0.08 Cr a year earlier and net profit was ₹0.04 Cr, against ₹0.05 Cr a year earlier (compared with Mar 2025). Promoters held 16.16% of Transpact Enterprises in Sep 2026, unchanged from Mar 2026.

Close 28 Oct 2026 ₹96.00 −128.30 −57.20% 1Y

Key Fundamentals

MicrocapHealthcare Equipment & SuppliesHealthcare
Market Cap
₹3.68 Cr
EBITDA
₹10.00 L
Return on Equity
15.12%
Debt to Equity
0.11
Book Value
₹13.75
EPS (TTM)
—
52W High
₹234.90
52W Low
₹81.47

Price-based figures as of 28 Oct 2026, 15:30 IST · TTM

Peer Comparison

Healthcare › Medical Equipment › Medical Equipment & Supplies

Poly Medicure
₹1,463.3047.0714,832 Cr4.780.24%10.18%13.33%2,115 Cr313 Cr
Fischer Medical Ventures
₹26.2969.181,721 Cr3.760.20%8.11%12.69%373 Cr24 Cr
Tarsons Products
₹308.15147.441,640 Cr2.580.66%2.26%4.82%468 Cr11 Cr
Q-Line Biotech
₹550.0026.071,283 Cr2.630.00%22.63%26.37%201 Cr34 Cr
Laxmi Dental
₹178.3831.80982 Cr4.030.00%10.83%11.51%289 Cr31 Cr
Hemant Surgical Industries
——832 Cr5.310.00%13.22%19.52%——
Transpact Enterprises (this company)
——4 Cr6.980.00%15.12%14.62%——
Median 7 companies₹308.1547.071,283 Cr4.030.00%10.83%13.33%373 Cr31 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Strengths

1
  • Company has reduced debt.

Weaknesses

6
  • Stock is trading at 6.76 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 16.2%
  • Company has a low return on equity of 0.00% over last 3 years.
  • Company has high debtors of 203 days.
  • Promoter holding has decreased over last 3 years: -16.0%

Technical Indicators

Oscillators

Neutral

Bearish
2
Neutral
5
Bullish
2

Overall

Bearish

Bearish
11
Neutral
5
Bullish
3

Moving Averages

Bearish

Bearish
9
Neutral
0
Bullish
1

Growth Rate

Revenue Growth
100% higher than 3Y

change over 1 year

Net Income Growth
700% higher than 3Y

change over 1 year

Cash Flow Change
111%

change over 1 year

EBITDA Margin Change
30.19%

change over 1 year Operating margin 55.56% · Mar 2026

Quarterly Results

Particulars Mar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
0.02
0
0.06
0
0.15
0
0
0
0
0
0.08
0.1
0.09
Expenses
0.04
0.06
0.02
0.23
0.14
0.03
0.03
0.03
0.03
0.03
0.02
0.03
0.04
Operating Profit
-0.02
-0.06
0.04
-0.23
0.01
-0.03
-0.03
-0.03
-0.03
-0.03
0.06
0.07
0.05
OPM %
-100%
—
66.67%
—
6.67%
—
—
—
—
—
75%
70%
55.56%
Other Income
0
0
0
0
0.01
0.05
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0.02
0.02
0.02
0.02
0.02
0
0
0
0.04
0.02
0.02
0.02
0.02
PBT
-0.04
-0.08
0.02
-0.25
0
0.02
-0.03
-0.03
-0.07
-0.05
0.04
0.05
0.03
Tax %
0%
0%
50%
0%
—
0%
0%
0%
0%
0%
0%
0%
-33.33%
Net Profit
-0.05
-0.08
0.01
-0.25
0
0.02
-0.03
-0.03
-0.06
-0.05
0.05
0.05
0.04
EPS (₹)
-1.29
-2.07
0.26
-6.46
0
0.52
-0.78
-0.78
-1.55
-1.29
1.29
1.29
1.03
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
0
0
0
0
0.13
0
0.03
0.15
0.38
0
0.08
0.18
Expenses
0
0.07
0.05
0.09
0.16
0.34
0.08
0.36
0.41
0.06
0.04
0.06
Operating Profit
0
-0.07
-0.05
-0.09
-0.03
-0.34
-0.05
-0.21
-0.03
-0.06
0.04
0.12
OPM %
—
—
—
—
-23.08%
-1950%
-166.67%
-140%
-7.89%
—
50%
66.67%
Other Income
0
0
0
0
-0.23
0.02
0.03
0.03
0
0
0
0
Interest
0
0
0
0
0
0.07
0
0
0
0
0
0
Depreciation
0
0
0
0
0.02
0.04
0.04
0.04
0.04
0.04
0.04
0.04
PBT
0
-0.07
-0.05
-0.09
-0.28
-0.43
-0.06
-0.22
-0.07
-0.1
0
0.08
Tax %
—
0%
0%
0%
3.57%
2.33%
16.67%
0%
0%
0%
—
0%
Net Profit
0
-0.07
-0.05
-0.09
-0.3
-0.43
-0.06
-0.22
-0.07
-0.09
0.01
0.08
EPS (₹)
0
-2.33
-1.67
-3
-10
-11.12
-1.55
-5.69
-1.81
-2.33
0.26
2.07
Div. Payout %
—
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.01
0.04
0.04
0.04
0.04
0.39
0.39
0.39
0.39
0.39
0.39
0.39
Reserves
0.13
0.1
0.12
0.03
-0.04
0.5
0.43
0.21
0.15
0.06
0.06
0.15
Borrowings
0.02
0.04
0.07
0.36
0.43
0.26
0.29
0.29
0.28
0.05
0.1
0.06
Other Liabilities
-0.01
0.01
0
0.04
0.09
0.15
0.27
0.21
0.22
0.16
0.15
0.18
Total Liabilities
0.15
0.19
0.23
0.47
0.52
1.3
1.38
1.1
1.04
0.66
0.7
0.78
Fixed Assets
0.13
0.13
0.18
0.18
0.35
0.31
0.27
0.24
0.2
0.16
0.13
0.09
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
0.02
0.06
0.05
0.29
0.17
0.99
1.11
0.86
0.84
0.5
0.57
0.69
Total Assets
0.15
0.19
0.23
0.47
0.52
1.3
1.38
1.1
1.04
0.66
0.7
0.78
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
-0.12
-0.05
-0.24
0.07
-1.14
0.01
-0.87
-0.01
0.39
-0.45
0.05
Investing
0
0
-0.05
0
-0.19
0
0
0
0
0
0
0
Financing
0
0.12
0.1
0.29
0.08
1.14
0.03
-0.29
0
0
0.05
-0.04
Net Cash Flow
0
0
0
0.05
-0.05
0
0.04
-1.16
-0.01
0.39
-0.4
0.01
Free Cash Flow
0
-0.12
-0.1
-0.24
-0.12
-1.14
0.01
-0.87
-0.01
0.39
-0.45
0.05
CFO/EBITDA
—
171
100
267
-233
335
-20
414
33
-650
-1,125
42
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
—
—
—
84.23
—
0
0
0
—
456
203
Inventory Days
—
—
—
—
329
—
—
13.04
19.21
—
—
0
Days Payable
—
—
—
—
183
—
—
130
115
—
—
—
Cash Conversion Cycle
—
—
—
—
230
—
0
-117
-96.05
—
456
203
Working Capital Days
—
—
—
—
-281
—
-2,677
-925
-384
—
2,008
1,034
ROCE %
0%
-41.18%
-24.39%
-27.27%
-11.63%
-45.57%
-5.31%
-22%
-8.19%
-15.15%
0%
13.91%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Transpact Enterprises insights

57 extracted metrics + investor summaries across FY12–FY26.

Shareholding Pattern

Public53.19%Promot.16.16%Others30.65%As ofSep 2026

Documents

Frequently Asked Questions about Transpact Enterprises

What does Transpact Enterprises Ltd do?
Incorporated in 2013, Transpact Enterprises Ltd deals in investment portfolio, Investment advisory, Corporate funding, Market consulting, for various clients[1]
Where is Transpact Enterprises Ltd (TRANSPACT) listed?
Transpact Enterprises Ltd trades under code 542765 on the BSE.
Which sector does Transpact Enterprises Ltd belong to?
Transpact Enterprises Ltd is classified under the Healthcare sector, in the Medical Equipment industry.
What is the market capitalisation of Transpact Enterprises Ltd?
Transpact Enterprises Ltd has a market capitalisation of ₹3.68 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Transpact Enterprises Ltd?
Over the last 52 weeks Transpact Enterprises Ltd has traded between ₹81.47 and ₹234.9 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Transpact Enterprises Ltd?
Transpact Enterprises Ltd reported a return on equity of 15.12%. Its debt-to-equity ratio is 0.11.

Company Information

Incorporated in 2013, Transpact Enterprises Ltd deals in investment portfolio, Investment advisory, Corporate funding, Market consulting, for various clients[1]

Website transpact.in
Listed 2019-09-05
Face Value ₹ 10
Shares Outstanding 3,83,219

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/542765.md for Transpact Enterprises Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Healthcare Equipment stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month